View in EDS

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.

Saved in:
Bibliographic Details
Title: Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.
Authors: Boxer, Adam L1 (AUTHOR), Qureshi, Irfan2 (AUTHOR), Ahlijanian, Michael2 (AUTHOR), Grundman, Michael3 (AUTHOR), Golbe, Lawrence I4 (AUTHOR), Litvan, Irene5 (AUTHOR), Honig, Lawrence S6 (AUTHOR), Tuite, Paul7 (AUTHOR), McFarland, Nikolaus R8 (AUTHOR), O'Suilleabhain, Padraig9 (AUTHOR), Xie, Tao10 (AUTHOR), Tirucherai, Giridhar S2 (AUTHOR), Bechtold, Clifford2 (AUTHOR), Bordelon, Yvette11 (AUTHOR), Geldmacher, David S12 (AUTHOR), Grossman, Murray13 (AUTHOR), Isaacson, Stuart14 (AUTHOR), Zesiewicz, Theresa15 (AUTHOR), Olsson, Tina16 (AUTHOR), Muralidharan, Kumar Kandadi16 (AUTHOR)
Source: Lancet Neurology. Jun2019, Vol. 18 Issue 6, p549-558. 10p.
Database: Academic Search Ultimate
Description
ISSN:14744422
DOI:10.1016/S1474-4422(19)30139-5